⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Livi®, the First FDA-Cleared After-Sex Absorption Device, Is Now Available
prnewswire.com
PFE
The Galien Foundation Announces 2026 International Prix Galien Award Nominees
prnewswire.com
AZN
MRK
BMY
GILD
JNJ
PFE
REGN
VRTX
MED
BFLY
EW
NVCR
NVO
IMCR
Generic Injectables Market Research Report 2026 - Revenue to Reach $285.61 Billion by 2031, Driven by Patent Expirations and Biosimilar Growth
globenewswire.com
PFE
BIIB
AMGN
REGN
BMY
GILD
ABBV
MRK
JNJ
BAX
VTRS
Long-Acting Contraception Market Report: Evaluating Hormonal vs. Non-Hormonal IUDs, Subdermal Implants, Injectables, and Strategies of Bayer, Merck, Pfizer, and CooperCompanies
globenewswire.com
MRK
PFE
CCO
ORGN
TEVA
VTRS
Acute Lymphoblastic Leukemia (ALL) Therapeutics Market Report 2026-2031 - Growth Sustained by Continued Clinical Innovation, Improving Pediatric Survival Outcomes and Broader MRD Adoption
globenewswire.com
AMGN
JAZZ
NVS
PFE
JNJ
GILD
MRK
ABBV
Co-Packaged Optics in the AI Data Center: 10-Year Market Forecast and Strategic Analysis: Evaluating Silicon Photonics, Switch ASICs, and Strategies of Nvidia, Broadcom, Intel, and Marvell
globenewswire.com
NVDA
AVGO
INTC
MRVL
AMD
IBM
GOOG
META
MSFT
CIEN
CSCO
COHR
GLW
DD
LITE
TE
AMAT
KLAC
ASML
AMCX
AMGN
AMZN
BIIB
BMY
COST
CSX
DIS
EA
EXC
GILD
HON
INTU
JD
LLY
LRCX
MAR
MDLZ
MU
NFLX
NTAP
ORCL
PEP
PFE
QCOM
SBUX
SMCI
SNY
TCOM
TMO
TXN
ULTA
VRTX
WFC
WMT
XOM
ZM
Cancer & Antibody Conjugates Patent Landscape Report: Evaluating 3,761 Patent Families, Linker-Payload Technologies, and Strategies of Roche, Daiichi Sankyo, Gilead, and AstraZeneca
globenewswire.com
GILD
AZN
PFE
BMY
ABBV
Portefeuille initial, offre aux particuliers et période d'accès au capital
prnewswire.com
AI
NVDA
GOOG
MSFT
AMZN
META
TSLA
AMD
INTC
QCOM
IBM
CRM
ADBE
PYPL
NFLX
UBER
LYFT
DDOG
SNOW
PLTR
UPST
COIN
MARA
RIOT
XOM
CVX
F
GM
RIVN
LCID
CRSP
MRNA
PFE
JNJ
ROKU
HOOD
SOFI
AMC
GME
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
globenewswire.com
PFE
VALN
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
businesswire.com
VALN
PFE